Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1129919 BETHESDA, MD
Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,859,560
-$919,737 QoQ
Shares Held
3,432
-26.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#382
of 877 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $16,343,377 across 32 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (11.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 40,027 $2,097,414
2 UTHR
UNITED THERAPEUTICS Corp
This page 		3,432 $1,859,560
3 NBIX
Neurocrine Biosciences Inc
 10,634 $1,792,254
4 BCRX
Biocryst Pharmaceuticals Inc
 134,034 $1,340,340
5 LQDA
Liquidia Corp
 7,836 $624,764
6 ZTS
Zoetis Inc.
 7,784 $559,358
7 INDV
Indivior Pharmaceuticals, Inc.
 13,462 $552,345
8 ELAN
Elanco Animal Health Inc
 22,419 $551,731

All Filings in UTHR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,859,560 3,432
2026-03-31 $2,779,297 4,687
2025-12-31 $2,576,578 5,288
2025-09-30 $2,198,337 5,244
2025-06-30 $2,291,903 7,976
2025-03-31 $2,484,347 8,059
2024-12-31 $2,790,258 7,908
2024-09-30 $3,813,560 10,642
2024-06-30 $4,025,834 12,638
2024-03-31 $1,676,956 7,300
2023-12-31 $1,597,500 7,265
2023-09-30 $1,752,299 7,758
2023-06-30 $1,749,664 7,926
2023-03-31 $1,560,329 6,967
2022-12-31 $1,830,944 6,584
2022-09-30 $1,369,135 6,539
2022-06-30 $1,621,674 6,882
2022-03-31 $1,406,933 7,842
2021-12-31 $1,768,398 8,184
2021-09-30 $1,725,269 9,347
2021-06-30 $1,810,605 10,092
2021-03-31 $1,712,677 10,239
2020-12-31 $1,729,950 11,397
2020-09-30 $996,971 9,871
2020-06-30 $1,384,361 11,441
2020-03-31 $919,187 9,693